Everest Enhances Regulatory Strategy and Capabilities with the Appointment of Kevin Barber as Senior Vice President of Global Regulatory Strategy and Submissions

TORONTO — July 30, 2025 — Everest Clinical Research, a quality and data-driven global CRO, announces the appointment of Kevin Barber, Ph.D., M.S., RAC, PMP as Senior Vice President of Global Regulatory Strategy and Submissions. In this role, Kevin will lead the expansion of Everest’s regulatory capabilities, overseeing strategy and execution from early clinical development planning through to global marketing applications.

Kevin brings more than 30 years of hands-on experience in product development, regulatory strategy, and clinical operations—working for both CROs and sponsor companies. Throughout his career, he has led more than 100 INDs/CTAs, contributed to over 80 marketing applications, and played a key role in 18 product approvals worldwide.

“Kevin’s unmatched depth in regulatory strategy, his hands-on approach to serving clients and teams, paired with an exceptional operational background, will enhance our ability to support small and mid-sized biopharma companies navigating complicated pathways,” said Jin Dai, Everest’s Chief Executive Officer. “We’re extremely excited to have him on board.”

Prior to joining Everest, Kevin was the Senior Vice President of Regulatory Strategy and Submissions at Rho, Inc., where he supported the build of the company’s regulatory strategy and product development consulting business. 

At Everest, Kevin will drive strategic regulatory leadership across Everest’s key service areas and support the company’s clients in planning and executing product development strategies from early development through marketing applications. He will focus on establishing foundations for regulatory excellence, expanding trial-enabling and startup support, enhancing agency engagement (FDA, EMA, and other global agencies), and providing cross-functional regulatory leadership across clinical operations and biometrics.

“I’m excited to join Everest at such a pivotal moment in its growth,” Kevin said. “As the organization expands its service offerings, there is a tremendous opportunity to build a strategic regulatory function to help our clients navigate the complex and evolving global regulatory landscape with confidence and clarity. I look forward to working with our talented teams at Everest to deliver regulatory solutions that accelerate development, proactively manage risks, and drive successful outcomes for patients and our partners.”